|
|||||
|
|
A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor,in healthy subjects: comment |
|
| Authors: | V. Gurewich R. Pannell |
| Affiliation: | 1. Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, USA;2. Vascular Laboratory, Inc., Cambridge, MA, USA |
| Abstract: | |
| Keywords: | |